Glycosphingolipid catabolism
REACTOME PATHWAYThe Glycosphingolipid catabolism pathway (Reactome ID: R-HSA-9840310) involves 7 genes and is affected by 14 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Glycosphingolipid catabolism
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | Zanamivir | — | 297 |
| 2 | Chlorhexidine | — | 299 |
| 3 | Genistein | — | 300 |
| 4 | 1-Deoxynojirimycin | — | 299 |
| 5 | trichostatic acid [Supplementary Concept] related to trichostatin | — | 300 |
| 6 | Iodoacetamide | — | 300 |
| 7 | Pindolol | — | 299 |
| 8 | Pseudoephedrine | — | 298 |
| 9 | stx64 | — | 2 |
| 10 | Dehydroepiandrosterone Sulfate | — | 300 |
| 11 | Oseltamivir | — | 297 |
| 12 | piceatannol | — | 300 |
| 13 | pirenperone | — | 22 |
| 14 | Bortezomib | — | 300 |
About the Glycosphingolipid catabolism Pathway
The Glycosphingolipid catabolism pathway is catalogued in Reactome (ID: R-HSA-9840310) and involves 7 genes. In the BiohacksAI corpus, 14 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ARSA, CTSA, GBA1, GLA, NEU2.